NMPA-approved traditional Chinese medicine-Pingwei Pill: new indication for colistin recovery against MCR-positive bacteria infection

• Main Authors: Qiushuang Sheng (Author), Runbao Du (Author), Cunhui Ma (Author), Yonglin Zhou (Author), Xue Shen (Author), Xiaoning Hou (Author), Lei Xu (Author), Li Li (Author), Xuming Deng (Author), Jianfeng Wang (Author)
• Format: Book
• Published: BMC, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The wide spread of plasmid-mediated colistin resistance by mobile colistin resistance (MCR) in Enterobacteriaceae severely limits the clinical application of colistin as a last-line drug against bacterial infection. The identification of colistin potentiator from natural plants o...